Rubin Jonathan — SEC Form 4 filings
SEC reporting owner CIK 1836067. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-26 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 927 shares, $36,292 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 52.
- Largest priced transaction: sale of 927 shares @ $39.15 ($36,292) in SUPERNUS PHARMACEUTICALS, INC., filed 2025-02-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 15 | — | 1 leg · 927 sh · $36,292 | 52 |
Form 4 filings — Rubin Jonathan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Option exercise (M): 750 @ $0 · Tax withholding (F): 363 @ $46.57 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2026-07-31 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 750 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 1,250 @ $0 · Tax withholding (F): 675 @ $50.69 · Disposition to issuer (D): 1,250 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 1,125 @ $0 · Tax withholding (F): 603 @ $51.35 · Grant/award (A): 750 @ $0 · Tax withholding (F): 369 @ $50.86 · Grant/award (A): 1,250 @ $0 · Tax withholding (F): 671 @ $0 · +3 more | EDGAR |
| 2026-02-20 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 13,500 (derivative) @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-09-26 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Option exercise (M): 1,875 @ $0 · Tax withholding (F): 840 @ $46.21 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 1,875 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Tax withholding (F): 314 @ $33.05 · Tax withholding (F): 577 @ $33.05 · Tax withholding (F): 577 @ $33.05 | EDGAR |
| 2025-02-24 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Option exercise (M): 1,875 @ $0 · Sale (S): 927 @ $39.15 · Grant/award (A): 750 @ $0 · Grant/award (A): 1,250 @ $0 · Grant/award (A): 1,250 @ $0 · Option exercise (M): 1,875 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-21 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 1,875 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Option exercise (M): 750 @ $0 · Tax withholding (F): 281 @ $35.59 · Option exercise (M): 1,875 @ $0 · Tax withholding (F): 821 @ $35.59 · Option exercise (M): 750 (derivative) @ $0 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 750 (derivative) @ $0 · Grant/award (A): 1,875 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 1,250 @ $0 · Tax withholding (F): 567 @ $29.06 · Disposition to issuer (D): 1,250 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 750 @ $0 · Tax withholding (F): 303 @ $27.94 · Disposition to issuer (D): 750 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836067 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →